The efficiency of plaque radiotherapy in the management of retinoblastoma
Purpose. To assess the tumor control and complications of ruthenium 106 (Ru-106) and strontium 90 (Sr-90) plaques radiotherapy for retinoblastoma.Material and methods. The study included 60 children with retinoblastoma who were treated in the Ocular Oncology and Radiology Service at the S. Fyodorov...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Publishing house "Ophthalmology"
2016-05-01
|
| Series: | Офтальмохирургия |
| Subjects: | |
| Online Access: | https://www.ophthalmosurgery.ru/jour/article/view/231 |
| _version_ | 1828057625566117888 |
|---|---|
| author | A. A. Yarovoy E. S. Bulgakova O. S. Krivovyaz T. L. Ushakova V. G. Polyakov |
| author_facet | A. A. Yarovoy E. S. Bulgakova O. S. Krivovyaz T. L. Ushakova V. G. Polyakov |
| author_sort | A. A. Yarovoy |
| collection | DOAJ |
| description | Purpose. To assess the tumor control and complications of ruthenium 106 (Ru-106) and strontium 90 (Sr-90) plaques radiotherapy for retinoblastoma.Material and methods. The study included 60 children with retinoblastoma who were treated in the Ocular Oncology and Radiology Service at the S. Fyodorov Eye Microsurgery Federal State Institution with plague radiotherapy between 2006 and 2015. The mean patient age at the plaque treatment was 22 months (from 5 to 74 months). Prior this treatment the management of the retinoblastoma was carried out in one hundred tumors (92% of cases) and included various combinations of treatments such as systemic and/or local chemotherapy, external beam radiotherapy, laser coagulation, thermotherapy and cryotherapy. Five retinoblastomas (8%) were managed by plaque radiotherapy without any previous treatment. The Ru-106 plaques were used in 68.5% of cases (72 tumor foci) and the Sr-90 plaques – in 31.5% of cases (33 tumors). The mean doses to the tumor apex were 89 Gy for Ru-106 and 190 Gy for Sr-90 plaques, and to the tumor base were 348 Gy for Ru-106 and 757 Gy for Sr-90 plaques.Results. A complete tumor control was achieved in 87% of cases during a mean follow-up of 3.5 months. The failures after the plaque radiotherapy in 11% of cases were controlled with the thermotherapy and in 6% of cases with the repeated plaque radiotherapy. Radiation complications included nonproliferative retinopathy in 19% of cases, proliferative retinopathy – 4%, papillopathy – 11%, retinal detachment – 2%, vitreous hemorrhage – 18%, cataract – 3%, glaucoma and scleral necrosis – 0%. The mean follow-up period was 27 months (from 2 to 72 months).Conclusion. Plaque radiotherapy should be considered as an important and effective option for retinoblastoma, especially in resistant and recurrent tumors after a failure of other methods to achieve the tumor control. Complications such as radiation retinopathy and papillopathy, vitreous hemorrhage and retinal detachment should be anticipated, depending on the location, size of the tumor and previous treatment. |
| first_indexed | 2024-04-10T21:15:09Z |
| format | Article |
| id | doaj.art-4cbef88080e04c99a5c9692e4368f9a7 |
| institution | Directory Open Access Journal |
| issn | 0235-4160 2312-4970 |
| language | Russian |
| last_indexed | 2024-04-10T21:15:09Z |
| publishDate | 2016-05-01 |
| publisher | Publishing house "Ophthalmology" |
| record_format | Article |
| series | Офтальмохирургия |
| spelling | doaj.art-4cbef88080e04c99a5c9692e4368f9a72023-01-20T12:34:50ZrusPublishing house "Ophthalmology"Офтальмохирургия0235-41602312-49702016-05-0101525810.25276/0235-4160-2016-1-52-58220The efficiency of plaque radiotherapy in the management of retinoblastomaA. A. Yarovoy0E. S. Bulgakova1O. S. Krivovyaz2T. L. Ushakova3V. G. Polyakov4The S. Fyodorov Eye Microsurgery Federal State InstitutionThe S. Fyodorov Eye Microsurgery Federal State InstitutionThe S. Fyodorov Eye Microsurgery Federal State InstitutionThe Research Institute of Pediatric Oncology and Hematology of the N.N. Blokhin Cancer Research Center of the Russian Academy of Medical SciencesThe Research Institute of Pediatric Oncology and Hematology of the N.N. Blokhin Cancer Research Center of the Russian Academy of Medical SciencesPurpose. To assess the tumor control and complications of ruthenium 106 (Ru-106) and strontium 90 (Sr-90) plaques radiotherapy for retinoblastoma.Material and methods. The study included 60 children with retinoblastoma who were treated in the Ocular Oncology and Radiology Service at the S. Fyodorov Eye Microsurgery Federal State Institution with plague radiotherapy between 2006 and 2015. The mean patient age at the plaque treatment was 22 months (from 5 to 74 months). Prior this treatment the management of the retinoblastoma was carried out in one hundred tumors (92% of cases) and included various combinations of treatments such as systemic and/or local chemotherapy, external beam radiotherapy, laser coagulation, thermotherapy and cryotherapy. Five retinoblastomas (8%) were managed by plaque radiotherapy without any previous treatment. The Ru-106 plaques were used in 68.5% of cases (72 tumor foci) and the Sr-90 plaques – in 31.5% of cases (33 tumors). The mean doses to the tumor apex were 89 Gy for Ru-106 and 190 Gy for Sr-90 plaques, and to the tumor base were 348 Gy for Ru-106 and 757 Gy for Sr-90 plaques.Results. A complete tumor control was achieved in 87% of cases during a mean follow-up of 3.5 months. The failures after the plaque radiotherapy in 11% of cases were controlled with the thermotherapy and in 6% of cases with the repeated plaque radiotherapy. Radiation complications included nonproliferative retinopathy in 19% of cases, proliferative retinopathy – 4%, papillopathy – 11%, retinal detachment – 2%, vitreous hemorrhage – 18%, cataract – 3%, glaucoma and scleral necrosis – 0%. The mean follow-up period was 27 months (from 2 to 72 months).Conclusion. Plaque radiotherapy should be considered as an important and effective option for retinoblastoma, especially in resistant and recurrent tumors after a failure of other methods to achieve the tumor control. Complications such as radiation retinopathy and papillopathy, vitreous hemorrhage and retinal detachment should be anticipated, depending on the location, size of the tumor and previous treatment.https://www.ophthalmosurgery.ru/jour/article/view/231retinoblastomaorgan-saving treatmentfocal treatmentbrachytherapy |
| spellingShingle | A. A. Yarovoy E. S. Bulgakova O. S. Krivovyaz T. L. Ushakova V. G. Polyakov The efficiency of plaque radiotherapy in the management of retinoblastoma Офтальмохирургия retinoblastoma organ-saving treatment focal treatment brachytherapy |
| title | The efficiency of plaque radiotherapy in the management of retinoblastoma |
| title_full | The efficiency of plaque radiotherapy in the management of retinoblastoma |
| title_fullStr | The efficiency of plaque radiotherapy in the management of retinoblastoma |
| title_full_unstemmed | The efficiency of plaque radiotherapy in the management of retinoblastoma |
| title_short | The efficiency of plaque radiotherapy in the management of retinoblastoma |
| title_sort | efficiency of plaque radiotherapy in the management of retinoblastoma |
| topic | retinoblastoma organ-saving treatment focal treatment brachytherapy |
| url | https://www.ophthalmosurgery.ru/jour/article/view/231 |
| work_keys_str_mv | AT aayarovoy theefficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT esbulgakova theefficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT oskrivovyaz theefficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT tlushakova theefficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT vgpolyakov theefficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT aayarovoy efficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT esbulgakova efficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT oskrivovyaz efficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT tlushakova efficiencyofplaqueradiotherapyinthemanagementofretinoblastoma AT vgpolyakov efficiencyofplaqueradiotherapyinthemanagementofretinoblastoma |